These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16243180)

  • 1. Bone regeneration in osseous defects using a resorbable nanoparticular hydroxyapatite.
    Thorwarth M; Schultze-Mosgau S; Kessler P; Wiltfang J; Schlegel KA
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1626-33. PubMed ID: 16243180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of de novo bone formation following application of autogenous bone to particulated anorganic bovine material in vivo.
    Thorwarth M; Schlegel KA; Wehrhan F; Srour S; Schultze-Mosgau S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):309-16. PubMed ID: 16504863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone regeneration in osseous defects-application of particulated human and bovine materials.
    Tudor C; Srour S; Thorwarth M; Stockmann P; Neukam FW; Nkenke E; Schlegel KA; Felszeghy E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):430-6. PubMed ID: 18206408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone healing with an in situ-formed bioresorbable polyethylene glycol hydrogel membrane in rabbit calvarial defects.
    Humber CC; Sándor GK; Davis JM; Peel SA; Brkovic BM; Kim YD; Holmes HI; Clokie CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):372-84. PubMed ID: 20060340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation.
    Thorwarth M; Wehrhan F; Schultze-Mosgau S; Wiltfang J; Schlegel KA
    Bone; 2006 Jan; 38(1):30-40. PubMed ID: 16257592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osseous defect regeneration using autogenous bone alone or combined with Biogran or Algipore with and without added thrombocytes. A microradiologic evaluation].
    Schlegel KA; Kloss FR; Schultze-Mosgau S; Neukam FW; Wiltfang J
    Mund Kiefer Gesichtschir; 2003 Mar; 7(2):112-8. PubMed ID: 12664257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal study of the bone substitute material Ostim within osseous defects in Göttinger minipigs].
    Spies C; Schnürer S; Gotterbarm T; Breusch S
    Z Orthop Unfall; 2008; 146(1):64-9. PubMed ID: 18324584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinus augmentation analysis revised: the gradient of graft consolidation.
    Busenlechner D; Huber CD; Vasak C; Dobsak A; Gruber R; Watzek G
    Clin Oral Implants Res; 2009 Oct; 20(10):1078-83. PubMed ID: 19519790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of bone reconstruction following application of bone matrix gelatin and autogenous bone grafts to alveolar defects: an animal study.
    Bayat M; Momen-Heravi F; Marjani M; Motahhary P
    J Craniomaxillofac Surg; 2010 Jun; 38(4):288-92. PubMed ID: 19910208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of cranial bone defects using a quick-setting hydroxyapatite cement and absorbable plates.
    Ascherman JA; Foo R; Nanda D; Parisien M
    J Craniofac Surg; 2008 Jul; 19(4):1131-5. PubMed ID: 18650747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo bone formation using bovine collagen and platelet-rich plasma.
    Schlegel KA; Donath K; Rupprecht S; Falk S; Zimmermann R; Felszeghy E; Wiltfang J
    Biomaterials; 2004 Oct; 25(23):5387-93. PubMed ID: 15130723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maxillary sinus augmentation with a porous synthetic hydroxyapatite and bovine-derived hydroxyapatite: a comparative clinical and histologic study.
    Mangano C; Scarano A; Perrotti V; Iezzi G; Piattelli A
    Int J Oral Maxillofac Implants; 2007; 22(6):980-6. PubMed ID: 18271380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monocortical critical size bone defect as an alternative experimental model in testing bone substitute materials.
    Schlegel KA; Lang FJ; Donath K; Kulow JT; Wiltfang J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):7-13. PubMed ID: 16831666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate: the importance of bioresorption to osteoconduction.
    Spence G; Phillips S; Campion C; Brooks R; Rushton N
    J Bone Joint Surg Br; 2008 Dec; 90(12):1635-40. PubMed ID: 19043138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study evaluating an in situ formed synthetic biodegradable membrane for guided bone regeneration in dogs.
    Jung RE; Lecloux G; Rompen E; Ramel CF; Buser D; Hammerle CH
    Clin Oral Implants Res; 2009 Feb; 20(2):151-61. PubMed ID: 19191792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical ridge augmentation using xenogenous bone blocks: a histomorphometric study in dogs.
    Rothamel D; Schwarz F; Herten M; Ferrari D; Mischkowski RA; Sager M; Becker J
    Int J Oral Maxillofac Implants; 2009; 24(2):243-50. PubMed ID: 19492639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous Titanium Granules in comparison with Autogenous Bone Graft in Femoral Osseous Defects: A Histomorphometric Study of Bone Regeneration and Osseointegration in Rabbits.
    Pepelassi E; Perrea D; Dontas I; Ulm C; Vrotsos I; Tangl S
    Biomed Res Int; 2019; 2019():8105351. PubMed ID: 31915704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic findings in sinus augmentation with autogenous bone chips versus a bovine bone substitute.
    Schlegel KA; Fichtner G; Schultze-Mosgau S; Wiltfang J
    Int J Oral Maxillofac Implants; 2003; 18(1):53-8. PubMed ID: 12608669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autogenous bone with or without hydroxyapatite bone substitute augmentation in rat calvarium within a plastic cap.
    Oginuma T; Sato S; Udagawa A; Saito Y; Arai Y; Ito K
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5 Suppl):S107-13. PubMed ID: 23063386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primates.
    Herford AS; Lu M; Buxton AN; Kim J; Henkin J; Boyne PJ; Caruso JM; Rungcharassaeng K; Hong J
    J Oral Maxillofac Surg; 2012 Mar; 70(3):703-16. PubMed ID: 21549480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.